BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24791475)

  • 21. Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era.
    van der Heul HU; Bilyk BL; McDowall KJ; Seipke RF; van Wezel GP
    Nat Prod Rep; 2018 Jun; 35(6):575-604. PubMed ID: 29721572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actinomycetes genome engineering approaches.
    Siegl T; Luzhetskyy A
    Antonie Van Leeuwenhoek; 2012 Oct; 102(3):503-16. PubMed ID: 22926833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
    Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering of natural product biosynthesis in actinobacteria.
    Bilyk O; Luzhetskyy A
    Curr Opin Biotechnol; 2016 Dec; 42():98-107. PubMed ID: 27058643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of the secondary metabolism of Streptomyces: new links and experimental advances.
    van Wezel GP; McDowall KJ
    Nat Prod Rep; 2011 Jul; 28(7):1311-33. PubMed ID: 21611665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical ecology of antibiotic production by actinomycetes.
    van der Meij A; Worsley SF; Hutchings MI; van Wezel GP
    FEMS Microbiol Rev; 2017 May; 41(3):392-416. PubMed ID: 28521336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of secondary metabolism in streptomycetes.
    Bibb MJ
    Curr Opin Microbiol; 2005 Apr; 8(2):208-15. PubMed ID: 15802254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotics production by an actinomycete isolated from the termite gut.
    Matsui T; Tanaka J; Namihira T; Shinzato N
    J Basic Microbiol; 2012 Dec; 52(6):731-5. PubMed ID: 22359219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Elements of regulatory systems of antibiotic biosynthesis in Streptomyces].
    Tabakov VIu; Voeĭkova TA
    Genetika; 1997 Nov; 33(11):1461-77. PubMed ID: 9480210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes.
    Onaka H
    J Antibiot (Tokyo); 2017 Jul; 70(8):865-870. PubMed ID: 28442735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development and application of ribosomal engineering in actinomycetes].
    Xie Y; Yao S; Li W; Shan R; Wu G; Tong T; Chen Q
    Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):546-564. PubMed ID: 35234381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial chromosomes to explore and to exploit biosynthetic capabilities of actinomycetes.
    Alduina R; Gallo G
    J Biomed Biotechnol; 2012; 2012():462049. PubMed ID: 22919271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combinatorial and synthetic biosynthesis in actinomycetes.
    Luzhetska M; Härle J; Bechthold A
    Fortschr Chem Org Naturst; 2010; 93():211-37. PubMed ID: 20556678
    [No Abstract]   [Full Text] [Related]  

  • 35. Marine actinomycetes as an emerging resource for the drug development pipelines.
    Zotchev SB
    J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodiscovery from rare actinomycetes: an eco-taxonomical perspective.
    Kurtböke DI
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1843-52. PubMed ID: 22297430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unearthing Hidden Chemical Potential from Discarded Actinobacterial Libraries.
    Timmermans ML; Ross AC
    Trends Biotechnol; 2020 Jan; 38(1):7-9. PubMed ID: 31785780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria.
    Hoshino S; Onaka H; Abe I
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):363-374. PubMed ID: 30488365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotechnological potential of actinomycetes in the 21st century: a brief review.
    de Souza Rodrigues R; de Souza AQL; Feitoza MDO; Alves TCL; Barbosa AN; da Silva Santiago SRS; de Souza ADL
    Antonie Van Leeuwenhoek; 2024 May; 117(1):82. PubMed ID: 38789815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of tripyrrole and beta-lactam secondary metabolites in Serratia: integration of quorum sensing with multiple new regulatory components in the control of prodigiosin and carbapenem antibiotic production.
    Fineran PC; Slater H; Everson L; Hughes K; Salmond GP
    Mol Microbiol; 2005 Jun; 56(6):1495-517. PubMed ID: 15916601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.